Intergroup study in elderly patients with AML to compare complete remission rate and overall survival after intermediate-dose or low-dose AraC.

被引：0

作者：

Lange, T.

Niederwieser, D.

Hoffmann, V.

Pfirrmann, M.

Maschmeyer, G.

Fischer, T.

Herold, M.

Sayer, H. G.

Junghanss, C.

Krahl, R.

Al-Ali, H. K.

Poenisch, W.

Vucinic, V.

Doelken, G.

Sauerland, M. C.

Heinecke, A.

Hoelzer, D.

Hehlmann, R.

Berdel, W. E.

Buchner, T.

机构：

[1] Univ Leipzig, D-04109 Leipzig, Germany

[2] Univ Leipzig, Dept Hematol Oncol & Hemostasis, D-04109 Leipzig, Germany

[3] Univ Munich, Munich, Germany

[4] LMU Muenchen, Inst Med Informat & Biometry, Munich, Germany

[5] Potsdam Klinikum, Potsdam, Germany

[6] Univ Magdeburg, D-39106 Magdeburg, Germany

[7] Helios Klinikum Erfurt, Erfurt, Germany

[8] Jena Uniklinikum, Jena, Germany

[9] Univ Rostock, D-18055 Rostock, Germany

[10] Univ Hosp Greifswald, Greifswald, Germany

[11] Univ Munster, D-48149 Munster, Germany

[12] Onkol Frankfurt, Frankfurt, Germany

[13] Heidelberg Univ, Med Fak Mannheim, Mannheim, Germany

[14] Univ Muenster Hosp, Munster, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期

关键词：

D O I：

10.1200/jco.2011.29.15_suppl.6618

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6618

引用

页数：1